Hepatitis E Diagnostic Tests Market Outlook:
Hepatitis E Diagnostic Tests Market size was over USD 66.61 million in 2025 and is projected to reach USD 103.44 million by 2035, growing at around 4.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of hepatitis E diagnostic tests is evaluated at USD 69.31 million.
With high infection incidence of hepatitis E, increasing infection levels, especially in developing regions, and a growing demand for prompt and accurate methods of diagnosis, the hepatitis E diagnostic tests market is witnessing a surge. For instance, the World Health Organization (WHO), estimates 20 million HEV infections worldwide every year, leading to an average of 3.3 million symptomatic cases of HEV infection.
Moreover, improved PCR techniques, point-of-care testing devices for diagnosing hepatitis E virus infections easily, and other advanced serological and molecular testing are transforming the diagnostic landscape. Key players such as Roche, Abbott Laboratories, and Bio-Rad Laboratories hold significant hepatitis E diagnostic tests market shares and continue research and development by investing in developing better and more cost-effective diagnostic solutions. All these early detection and management alternatives with digital health technologies including mobile health applications are making the market foothold a strong presence and growth.
